Anti–Tumor Necrosis Factor-α Monotherapy Versus Combination Therapy with an Immunomodulator in IBD - Université de Lorraine Access content directly
Journal Articles Gastroenterology Clinics of North America Year : 2014
No file

Dates and versions

hal-01687233 , version 1 (18-01-2018)

Identifiers

Cite

Parambir Dulai, Corey Siegel, Laurent Peyrin-Biroulet. Anti–Tumor Necrosis Factor-α Monotherapy Versus Combination Therapy with an Immunomodulator in IBD. Gastroenterology Clinics of North America, 2014, 43 (3), pp.441 - 456. ⟨10.1016/j.gtc.2014.05.009⟩. ⟨hal-01687233⟩
13 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More